You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced esophageal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Advanced Esophageal Cancer Trial (HR070803)

Not yet recruiting
  • Advanced Esophageal Cancer
  • (no location specified)
Jun 15, 2022

Advanced Esophageal Cancer Trial in Guangzhou (Combination therapy)

Recruiting
  • Advanced Esophageal Cancer
  • Combination therapy
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Jul 12, 2022

Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)

Not yet recruiting
  • Esophageal Neoplasms
  • +2 more
  • (no location specified)
Nov 20, 2022

Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)

Active, not recruiting
  • Esophageal Carcinoma
  • Rochester, New York
    University of Rochester
Aug 17, 2022

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)

Active, not recruiting
Has Results
  • Esophageal Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Apr 7, 2022

Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)

Enrolling by invitation
  • Esophageal Carcinoma
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Esophageal Cancer Trial in Groningen (Fluorescence endoscopy using durvalumab-680LT)

Not yet recruiting
  • Esophageal Cancer
  • Fluorescence endoscopy using durvalumab-680LT
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 4, 2022

Efficacy of PD-1 Monoclonal Antibody

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • PD-1 Inhibitor
    • Guangzhou, China
      Nanfang Hospital
    Jul 5, 2022

    Immune Checkpoint Inhibitors and Chemotherapy for Advanced

    Completed
    • Esophageal Cancer
      • Guangzhou, Guangdong, China
      • +1 more
      Mar 15, 2022

      Esophageal Cancer Trial in Calgary (Carboplatin and Taxol (paclitaxel), External Beam Radiation)

      Recruiting
      • Esophageal Cancer
      • Carboplatin and Taxol (paclitaxel)
      • External Beam Radiation
      • Calgary, Alberta, Canada
        Tom Baker Cancer Centre
      Mar 23, 2022

      Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced

      Recruiting
      • Esophageal Neoplasms
      • an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
      • Zhengzhou, Henan, China
        The First Affiliated Hospital of Zhengzhou University
      Apr 21, 2022

      Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

      Not yet recruiting
      • Esophagus Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Nov 20, 2023

      Esophageal Cancer, Gastric Cancer, Colorectal Cancer Trial in Beijing (SI-B003, BL-B01D1)

      Not yet recruiting
      • Esophageal Cancer
      • +2 more
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Aug 22, 2023

      Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)

      Recruiting
      • Esophageal Cancer
      • Utidelone and anlotinib
      • Weihui, Henan, China
      • +2 more
      May 10, 2023

      Squamous Cell Carcinoma of Esophagus Trial in Hong Kong (Andrographis Paniculata)

      Completed
      • Squamous Cell Carcinoma of Esophagus
      • Andrographis Paniculata
      • Hong Kong, Outside Of US & Canada, China
        Department of Surgery, Faculty of Medicine, The Chinese Universi
      Nov 5, 2021

      Esophageal Cancer Trial (Tislelizumab, Radiation, Paclitaxel)

      Not yet recruiting
      • Esophageal Cancer
      • (no location specified)
      Nov 18, 2022

      Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,

      Recruiting
      • Esophageal Squamous Cell Carcinoma (ESCC)
      • Pembrolizumab
      • +5 more
      • Milan, Lombardia, Italy
      • +13 more
      Jan 3, 2023

      Esophagus SCC Trial in Jinan (Sintilimab Injection plus Paclitaxel and Cisplatin, Paclitaxel and Cisplatin)

      Withdrawn
      • Esophagus SCC
      • Sintilimab Injection plus Paclitaxel and Cisplatin
      • Paclitaxel and Cisplatin
      • Jinan, Shandong, China
        Qilu Hospital of Shandong University
      Apr 19, 2022

      Esophageal Cancer Trial in Tianjin (Arm A, Arm B)

      Not yet recruiting
      • Esophageal Cancer
      • Arm A
      • Arm B
      • Tianjin, Tianjin, China
        Tianjin Cancer Hospital
      Sep 24, 2023

      Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinomas
      • +3 more
      • chemotherapy combined with PD-1 inhibitors
      • (no location specified)
      Nov 17, 2022

      Localized Stage I-III Esophageal Cancer, Gastroesophageal Junction Cancer Trial in United States (nutritional and functional

      Completed
      • Localized Stage I-III Esophageal Cancer
      • Gastroesophageal Junction Cancer
      • nutritional and functional assessments
      • Basking Ridge, New Jersey
      • +6 more
      Mar 7, 2022

      Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

      Not yet recruiting
      • Esophageal Cancer
      • +2 more
      • (no location specified)
      Aug 21, 2023